These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 19793436

  • 1. Results of the external quality assessment of Mycobacterium tuberculosis drug susceptibility testing in Russia, 2005-2007.
    Shulgina MV, Malakhov VN, Hoffner SE, Haile M, Wright A.
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1294-300. PubMed ID: 19793436
    [Abstract] [Full Text] [Related]

  • 2. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998.
    Laszlo A, Rahman M, Espinal M, Raviglione M, WHO/IUATLD Network of Supranational Reference Laboratories.
    Int J Tuberc Lung Dis; 2002 Sep; 6(9):748-56. PubMed ID: 12234129
    [Abstract] [Full Text] [Related]

  • 3. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
    Laszlo A, Rahman M, Raviglione M, Bustreo F.
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):231-8. PubMed ID: 9432369
    [Abstract] [Full Text] [Related]

  • 4. [The external quality assessment for Mycobacterium tuberculosis drug susceptibility testing by proficiency testing panel to the commercial laboratories].
    Mitarai S, Committee for Mycobacterial Examinations, Japanese Society for Tuberculosis.
    Kekkaku; 2005 Apr; 80(4):349-58. PubMed ID: 15991600
    [Abstract] [Full Text] [Related]

  • 5. External quality control of Mycobacterium tuberculosis drug susceptibility testing: results of two rounds in endemic countries.
    Fattorini L, Iona E, Cirillo D, Migliori GB, Orefici G, Aziz M, Wright A, Tafaj S, Baig B, Mulliqi G, Maungate S, Cuna Z, Al-Busaidy S, Al-Suwaidi Z, Ceyhan I.
    Int J Tuberc Lung Dis; 2008 Feb; 12(2):214-7. PubMed ID: 18230256
    [Abstract] [Full Text] [Related]

  • 6. [Anti-tuberculosis drug resistance survey in Japan, 2002: external quality assessment of results].
    Tuberculosis Research Committee.
    Kekkaku; 2007 Mar; 82(3):155-64. PubMed ID: 17444118
    [Abstract] [Full Text] [Related]

  • 7. Proficiency analysis of drug susceptibility testing by national-level tuberculosis reference laboratories from 1995 to 2003.
    Bai GH, Kim SJ, Chang CL, National and Regional Tuberculosis Reference Laboratories.
    J Clin Microbiol; 2007 Nov; 45(11):3626-30. PubMed ID: 17855570
    [Abstract] [Full Text] [Related]

  • 8. Proficiency of drug susceptibility testing for Mycobacterium tuberculosis in Taiwan.
    Jou R, Chiang CY, Yu CY, Wu MH.
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1142-7. PubMed ID: 19723405
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antimicrobial susceptibility testing of Mycobacterium tuberculosis (EUCAST document E.DEF 8.1)--report of the Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
    Drobniewski F, Rüsch-Gerdes S, Hoffner S, Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
    Clin Microbiol Infect; 2007 Dec; 13(12):1144-56. PubMed ID: 17727670
    [Abstract] [Full Text] [Related]

  • 11. [A study on resistance of Mycobacterium tuberculosis to four first-line anti-tuberculosis drugs in Japan: comparison of results in the local facilities and in the reference laboratory, in 1997].
    Hirano K, Wada M, Abe C, Aoyagi T.
    Kekkaku; 2001 Jun; 76(6):461-71. PubMed ID: 11494526
    [Abstract] [Full Text] [Related]

  • 12. Has the time come to discontinue proficiency testing?
    Salfinger M, Ahmedov S.
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1193. PubMed ID: 19793421
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Analysis on quality control of drug susceptibility testing in the surveillance of drug resistance in tuberculosis in Henan].
    Xu J, Peng Y, Wang G.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Dec; 21(12):724-6. PubMed ID: 11480073
    [Abstract] [Full Text] [Related]

  • 15. [External quality assessment of drug susceptibility testing for Mycobacterium tuberculosis].
    Mitarai S, Committee for Mycobacterial Examinations, Japanese Society for Tuberculosis.
    Kekkaku; 2006 Aug; 81(8):501-9. PubMed ID: 16972653
    [Abstract] [Full Text] [Related]

  • 16. [Standardization of laboratory tests for tuberculosis and their proficiency testing].
    Abe C.
    Kekkaku; 2003 Aug; 78(8):541-51. PubMed ID: 14509226
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The quality of bacteriological detection and determination of drug sensitivity of Mycobacterium tuberculosis by the participants of the External Clinical Laboratory Study Quality Assessment made by the Federal System in 2002-2003].
    Malakhov VN, Irtuganova OA, Khaĭdukova IL, Levi DT, Golyshevskaia VI, Erokhin VV.
    Probl Tuberk Bolezn Legk; 2005 Aug; (4):6-11. PubMed ID: 15938496
    [Abstract] [Full Text] [Related]

  • 19. [BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis: a study using external quality assessment strains].
    Kobayashi I, Abe C, Mitarai S.
    Kekkaku; 2006 Feb; 81(2):57-62. PubMed ID: 16529006
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.